Bicocca Open Archive

Logo unimib boa
PESCI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.921
EU - Europa 5.417
AS - Asia 2.657
SA - Sud America 291
AF - Africa 33
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.765
SG - Singapore 1.083
IT - Italia 998
DE - Germania 942
RU - Federazione Russa 842
CN - Cina 771
SE - Svezia 764
IE - Irlanda 613
UA - Ucraina 346
HK - Hong Kong 333
BR - Brasile 265
GB - Regno Unito 235
FR - Francia 161
AT - Austria 155
ID - Indonesia 149
CA - Canada 141
FI - Finlandia 128
VN - Vietnam 95
IN - India 82
DK - Danimarca 62
TR - Turchia 45
NL - Olanda 44
BE - Belgio 34
CZ - Repubblica Ceca 27
JP - Giappone 14
ES - Italia 13
PK - Pakistan 13
IR - Iran 10
CH - Svizzera 9
RO - Romania 9
ZA - Sudafrica 9
IQ - Iraq 8
KR - Corea 8
AU - Australia 7
BD - Bangladesh 7
CL - Cile 7
MX - Messico 7
AR - Argentina 6
MA - Marocco 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
AL - Albania 4
BG - Bulgaria 4
EC - Ecuador 4
GR - Grecia 4
IL - Israele 4
PA - Panama 4
SC - Seychelles 4
CO - Colombia 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
PL - Polonia 3
UZ - Uzbekistan 3
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
VE - Venezuela 2
A1 - Anonimo 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 19.334
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.538
Fairfield 907
Woodbridge 862
Chandler 851
Singapore 719
Frankfurt am Main 627
Dublin 594
Houston 576
Wilmington 548
Ashburn 530
Dearborn 351
Jacksonville 341
Seattle 340
Hong Kong 331
New York 308
Cambridge 291
Princeton 240
Milan 230
Santa Clara 195
Jakarta 145
Nanjing 143
Vienna 136
Shanghai 120
Altamura 113
Lawrence 105
Beijing 73
Guangzhou 60
San Diego 59
Council Bluffs 57
Boardman 56
Lachine 56
Dong Ket 52
Helsinki 49
Nanchang 48
Moscow 43
Fremont 42
Toronto 36
Andover 33
Hebei 33
Nuremberg 33
Brussels 32
Jinan 32
Los Angeles 32
Shenyang 30
Lissone 26
Jiaxing 24
Tianjin 24
Monza 22
Brno 21
London 20
Düsseldorf 19
Lappeenranta 19
Norwalk 19
Rome 19
Falls Church 18
Hangzhou 18
Munich 18
Ottawa 17
São Paulo 17
Brescia 15
Mountain View 15
Ningbo 15
Changsha 14
Zhengzhou 13
Pune 12
Edmonton 11
Florence 11
Hefei 11
Belo Horizonte 10
Brasília 10
Beauharnois 9
Kiev 9
Kocaeli 9
Paris 9
Phoenix 9
Chicago 8
Desio 8
Genoa 8
Kunming 8
Tappahannock 8
Turin 8
Auburn Hills 7
Dallas 7
Leawood 7
Newark 7
Washington 7
Amsterdam 6
Ansbach 6
Bari 6
Berlin 6
Bologna 6
Groningen 6
Guarulhos 6
Montréal 6
Naples 6
Orange 6
Palermo 6
Porto Alegre 6
Redmond 6
Sacramento 6
Totale 13.647
Salva come PNG Salva come JPEG
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 366
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 322
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 307
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 304
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 304
Regional differences in bronchial reactivity assessed by respiratory impedance 247
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 246
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 246
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 237
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 232
Dyspnea in crackling lungs 228
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 220
Impact of traffic-related air pollution on pulmonary oxidative stress 217
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis 215
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 208
Characterization of bronchiectasis in the elderly 204
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 204
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 204
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study 204
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 203
Renal involvement in Churg-Strauss syndrome 202
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 200
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 199
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 199
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 199
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 197
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 197
Clinical phenotypes in adult patients with bronchiectasis 195
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 192
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 191
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 191
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 191
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 190
C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool 190
Persistence with inhaled corticosteroids reduces the risk of exacerbation among adults with asthma: A real-world investigation 190
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 190
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? 187
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 187
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 185
A 61-year-old female with chronic cough and purulent sputum 183
COPD: maximization of bronchodilation 183
Il lavaggio broncoalveolare nelle pneumopatie infiltrative diffuse 182
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 182
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 181
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 179
Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury 177
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 177
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 175
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 175
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? 173
Metallic elements in exhaled breath condensate of patients with interstitial lung diseases 169
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 169
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 167
Can healthcare utilization data reliably capture cases of chronic respiratory diseases? A cross-sectional investigation in Italy 163
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis 161
The management of community-acquired pneumonia in the elderly 161
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 161
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study 161
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 160
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 160
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 158
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 157
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 156
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 154
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 149
A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support 147
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 146
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 144
History of lung volume reduction procedures 144
Interstitial lung diseases in a lung cancer screening trial 141
Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial 139
Long-term macrolides in diffuse interstitial lung diseases 139
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 137
The bronchiectasis severity index. An international derivation and validation study 137
Respiratory system involvement in systemic vasculitides 136
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 136
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 135
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial 133
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 131
Alveolar Diseases 128
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 128
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 128
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 126
Respiratory system involvement in ANCA-associated systemic vasculitides 125
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 125
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 124
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? 122
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 120
Bronchoalveolar lavage in intensive care units 120
The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis 119
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 118
Outcome and prognostic factors during the course of primary small-vessel vasculitides 112
Reticular Diseases 112
Cryoglobulinemia 112
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 112
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 110
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 110
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 109
Respiratory System Involvement in Antineutrophil Cytoplasmic-associated Vasculitides: Clinical, pathological, radiological and therapeutic considerations 109
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 109
Totale 17.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020416 0 0 0 0 0 0 0 0 0 185 152 79
2020/20213.017 112 111 256 348 281 265 291 346 281 312 169 245
2021/20221.968 194 206 232 210 109 161 65 95 75 140 156 325
2022/20233.101 347 865 350 289 186 471 36 179 215 22 82 59
2023/20241.995 52 61 107 97 247 551 367 90 122 33 32 236
2024/20253.737 282 524 250 205 411 247 258 226 520 814 0 0
Totale 20.029